Crosstalk signaling in targeted melanoma therapy. - Wikidata - wikimedia - TriplyDB

Crosstalk signaling in targeted melanoma therapy.

Crosstalk signaling in targeted melanoma therapy.

http://www.wikidata.org/entity/Q38757522

about

Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma.BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1

P2860

Q39434922-42EED465-9F4A-441A-98EB-03BEF92419B5 Q58712577-553A1E6A-FF6E-483D-A71C-7D3F9DC64A8A

P2860

Crosstalk signaling in targeted melanoma therapy.

http://www.wikidata.org/entity/Q38757522

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Crosstalk signaling in targeted melanoma therapy.

@en

type

label

Crosstalk signaling in targeted melanoma therapy.

@en

prefLabel

Crosstalk signaling in targeted melanoma therapy.

@en

P1433

Q38757522-EC582EE3-696D-4B30-91F9-1F462FD50E48

P1476

Q38757522-FFF5562D-4609-4D76-BF31-693B0D0B4206

P2093

Q38757522-B8EF126F-E735-45F5-A7B1-BE53178AA8DE

P2860

Q38757522-05FDD9E9-22B9-4C97-90AC-235CA2A8F977

Q38757522-0729CE6F-1CD7-4E65-8A68-D153BB2EAE7B

Q38757522-079904D1-179B-41DE-AAAE-44EE941438CC

Q38757522-0B219863-665C-413B-AD7E-79C74D33924C

Q38757522-1196BF17-B5AA-499B-9F31-253B4D0408FD

Q38757522-11B6E0CF-7E74-4310-852E-F6483E97F8D1

Q38757522-136C22BF-553D-4379-BF31-ADF090383AA7

Q38757522-14060FBF-8FFD-404E-A833-38C230C9F0BD

Q38757522-21680968-6E78-4A28-9EA3-C677CB3263B0

Q38757522-2543FA3C-59E4-4515-9794-0DA717D182D0

P2888

Q38757522-083BF9E6-990C-4935-9C05-9C4ECE2A9B71

P304

Q38757522-9DBBC420-66EF-45A1-AE6B-5E77D5E4A8E4

P31

Q38757522-F416FEC7-D62A-4CDA-B01C-E6FB2AB4FFB9

P356

Q38757522-9FEA7270-A5EC-4E38-91E6-E260BCF4B833

P433

Q38757522-1FCE8926-FF5C-4C82-A4A0-9ABE11932ADF

P478

Q38757522-302D6095-7B30-49F2-8628-3B6992B59E59

P577

Q38757522-2920A7A3-7D9F-475D-8B98-303F489B7436

P6179

Q38757522-612A898C-A625-461D-B681-CF6016A2E74E

P698

Q38757522-02965F41-151F-4B35-AB6E-E546ABDB03C2

P356

S10555-017-9659-Z

P1433

Cancer and Metastasis Reviews

P1476

Crosstalk signaling in targeted melanoma therapy.

@en

P2093

Svenja Meierjohann

http://www.w3.org/2001/XMLSchema#string

P2860

Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment

Expression and functional role of negative signalling regulators in tumour development and progression.

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Mutations of the BRAF gene in human cancer

P2888

s10555-017-9659-z

P304

23-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-017-9659-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083823131

http://www.w3.org/2001/XMLSchema#string

P698

28197745

http://www.w3.org/2001/XMLSchema#string